These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10221376)

  • 1. Persistence with estrogen therapy in a postmenopausal Medicaid population.
    Kotzan JA; Martin BC; Wade WE
    Pharmacotherapy; 1999 Mar; 19(3):363-9. PubMed ID: 10221376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of race and fractures on mortality in a postmenopausal Medicaid population.
    Kotzan JA; Martin BC; Reeves JH; Wade W
    Clin Ther; 1999 Nov; 21(11):1988-2000. PubMed ID: 10890268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women.
    Chlebowski RT; Aragaki AK; Anderson GL; Prentice RL
    Cancer; 2020 Jul; 126(13):2956-2964. PubMed ID: 32212335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal estrogen use among African American and white patients at an urban clinic.
    Jahnige K; Fiebach N
    J Womens Health; 1997 Feb; 6(1):93-101. PubMed ID: 9065378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in estrogen use among middle-aged and older women.
    Bartman BA; Moy E
    Womens Health Issues; 1998; 8(1):32-44. PubMed ID: 9504037
    [No Abstract]   [Full Text] [Related]  

  • 6. Estrogen replacement therapy is underutilized among postmenopausal women at high risk for coronary heart disease.
    Massey CV; Hupp CH; Kreisberg M; Alpert MA; Hoff C
    Am J Med Sci; 2000 Aug; 320(2):124-7. PubMed ID: 10981488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous estrogen as mediator of racial differences in bioactive insulin-like growth factor-I levels among postmenopausal women.
    Jung SY; Vitolins MZ; Paskett ED; Chang S
    J Gerontol A Biol Sci Med Sci; 2015 Apr; 70(4):495-502. PubMed ID: 25238773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of menopausal vasomotor symptoms over the menopause transition.
    Avis NE; Crawford SL; Greendale G; Bromberger JT; Everson-Rose SA; Gold EB; Hess R; Joffe H; Kravitz HM; Tepper PG; Thurston RC;
    JAMA Intern Med; 2015 Apr; 175(4):531-9. PubMed ID: 25686030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of compliance with pediatric preventive care guidelines among Medicaid beneficiaries.
    Hakim RB; Bye BV
    Pediatrics; 2001 Jul; 108(1):90-7. PubMed ID: 11433059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE).
    Handa VL; Landerman R; Hanlon JT; Harris T; Cohen HJ
    J Am Geriatr Soc; 1996 Jan; 44(1):1-6. PubMed ID: 8537578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of postmenopausal female hormone use among black women in the United States.
    Rosenberg L; Palmer JR; Rao RS; Adams-Campbell LL
    Obstet Gynecol; 1998 Mar; 91(3):454-8. PubMed ID: 9491877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in prescription drug utilization and expenditures between Blacks and Whites in the Georgia Medicaid population.
    Khandker RK; Simoni-Wastila LJ
    Inquiry; 1998; 35(1):78-87. PubMed ID: 9597019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in tumor grade among women with endometrial cancer.
    Hill HA; Coates RJ; Austin H; Correa P; Robboy SJ; Chen V; Click LA; Barrett RJ; Boyce JG; Kotz HL
    Gynecol Oncol; 1995 Feb; 56(2):154-63. PubMed ID: 7896178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial differences in medication compliance and healthcare utilization among hypertensive Medicaid recipients: fixed-dose vs free-combination treatment.
    Dickson M; Plauschinat CA
    Ethn Dis; 2008; 18(2):204-9. PubMed ID: 18507275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of postmenopausal female hormone use among black women in the United States.
    Ransom SA; Sauer HJ
    Obstet Gynecol; 1998 Jul; 92(1):159-60. PubMed ID: 9649114
    [No Abstract]   [Full Text] [Related]  

  • 16. Is Medicaid pronatalist? The effect of eligibility expansions on abortions and births.
    Joyce T; Kaestner R; Kwan F
    Fam Plann Perspect; 1998; 30(3):108-13, 127. PubMed ID: 9635258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
    DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
    J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of postmenopausal hormone replacement therapy by African American women. The importance of physician discussion.
    McNagny SE; Jacobson TA
    Arch Intern Med; 1997 Jun; 157(12):1337-42. PubMed ID: 9201008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in US women 18 to 64 years old.
    Hsu CD; Wang X; Habif DV; Ma CX; Johnson KJ
    Cancer; 2017 Aug; 123(16):3125-3131. PubMed ID: 28440864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women.
    Rosenberg L; Bethea TN; Viscidi E; Hong CC; Troester MA; Bandera EV; Haiman CA; Kolonel LN; Olshan AF; Ambrosone CB; Palmer JR
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26613937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.